ProfoundBio is a Biotech company based in Seattle. It has raised $250M in total funding. Latest round: Series B.
ProfoundBio is a Biotech company based in Seattle. ProfoundBio has raised $250M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in February 2024. The round record for ProfoundBio runs through 2024; nothing later has been disclosed. Investors on record include Ally Bridge Group, Nextech Invest, T. Rowe Price, Janus Henderson Investors, RA Capital Management, OrbiMed. 6 distinct backers are named across the disclosed rounds.
Round data for ProfoundBio is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Seattle and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026